TVIS20010741
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr17 |
44616177 |
44616178 |
q21.31 |
- |
High-grade squamous intraepithelial lesions |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010742
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr17 |
45120465 |
45120466 |
q21.31 |
PLCD3 |
High-grade squamous intraepithelial lesions |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010743
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr14 |
53825501 |
55712832 |
q22.2,q22.3 |
ENSG00000231922, MIR5580, ENSG00000287156, ATP5F1CP1, ENSG00000297446, ENSG00000306082, ENSG00000258753, ENSG00000307190, RNU6ATAC9P, MIR4308, FDPSP3, ENSG00000304580, ENSG00000305238, RPSAP13, ENSG00000289523, ENSG00000304907, ENSG00000279392, ENSG00000299807, COX5AP1, ENSG00000239686, Metazoa_SRP, CHMP4BP1, HMGN1P1, RPL21P6, RPL7AP4, ABI1P1, Y_RNA, BMP4, ENSG00000300222, CDKN3, CNIH1, GMFB, ENSG00000295290, SAMD4A-AS1, GCH1, WDHD1, SOCS4, MAPK1IP1L, LGALS3, ENSG00000293989, ENSG00000258050, ENSG00000299791, FBXO34-AS1, ENSG00000258455, ATG14, ENSG00000300954, ENSG00000296983, LINC02331, ENSG00000295303, ENSG00000297427, ENSG00000300202, SAMD4A, ENSG00000307927, DLGAP5, FBXO34, TBPL2, DDHD1-DT, CGRRF1, KTN1-AS1, KTN1 |
High-grade squamous intraepithelial lesions |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010744
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr14 |
53825501 |
55712832 |
q22.2,q22.3 |
ENSG00000231922, MIR5580, ENSG00000287156, ATP5F1CP1, ENSG00000297446, ENSG00000306082, ENSG00000258753, ENSG00000307190, RNU6ATAC9P, MIR4308, FDPSP3, ENSG00000304580, ENSG00000305238, RPSAP13, ENSG00000289523, ENSG00000304907, ENSG00000279392, ENSG00000299807, COX5AP1, ENSG00000239686, Metazoa_SRP, CHMP4BP1, HMGN1P1, RPL21P6, RPL7AP4, ABI1P1, Y_RNA, BMP4, ENSG00000300222, CDKN3, CNIH1, GMFB, ENSG00000295290, SAMD4A-AS1, GCH1, WDHD1, SOCS4, MAPK1IP1L, LGALS3, ENSG00000293989, ENSG00000258050, ENSG00000299791, FBXO34-AS1, ENSG00000258455, ATG14, ENSG00000300954, ENSG00000296983, LINC02331, ENSG00000295303, ENSG00000297427, ENSG00000300202, SAMD4A, ENSG00000307927, DLGAP5, FBXO34, TBPL2, DDHD1-DT, CGRRF1, KTN1-AS1, KTN1 |
High-grade squamous intraepithelial lesions |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010745
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr6 |
126248596 |
126248597 |
q22.32 |
- |
High-grade squamous intraepithelial lesions |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010746
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr6 |
107221398 |
107226375 |
q21 |
PDSS2 |
High-grade squamous intraepithelial lesions |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010747
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr20 |
5751892 |
5751893 |
p12.3 |
SHLD1 |
ASCHL |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010748
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr13 |
73626724 |
73626725 |
q22.1 |
ENSG00000303224, LINC00393 |
ASCHL |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010749
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr2 |
1608294 |
1608295 |
p25.3 |
ENSG00000228613 |
Squamous intraepithelial lesion |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |
TVIS20010750
|
Human Papillomavirus |
- |
- |
- |
- |
hg38 |
chr2 |
133183995 |
133185219 |
q21.2 |
NCKAP5 |
Squamous intraepithelial lesion |
Cervical cancer |
Double-capture preparation and sequencing |
30728408 |
2019 |
ViMIC |